RICHARD COLE: Open Payments
NPI 1972500668 · STUART, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 70 payments from 23 companies in 2025. Trend: 2023 $1,440 · 2024 $1,389 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $228 |
| ABBVIE INC. | 12 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $110 |
| Novo Nordisk Inc | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| GENZYME CORPORATION | 3 | $65 |
| Verona Pharma, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Amgen Inc. | 3 | $48 |
| Seqirus USA Inc | 2 | $40 |
Products named: NURTEC ODT, CAPLYTA, HETLIOZ, QULIPTA, DUPIXENT, Ozempic, Ohtuvayre, ELIQUIS.
Industry payments across VA — which companies pay providers there.
